Gene-edited Spray-on Skin Cells May Show Promise for DEB

Gene-edited Spray-on Skin Cells May Show Promise for DEB

315720

Gene-edited Spray-on Skin Cells May Show Promise for DEB

A gene-edited skin cell therapy — called Spray-On Skin cells — promotes skin healing by correcting the mutation associated with recessive dystrophic epidermolysis bullosa (DEB), preclinical research from Avita Medical shows. “These data, while early, demonstrate promise … for treatment of epidermolysis bullosa with gene-corrected skin cells,” Mike Perry, PhD, CEO of Avita, said in a press release. The research, which the company says “successfully established proof of concept in … key areas of cell-based gene therapy,”…

You must be logged in to read/download the full post.